HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jacquier, A. Articles by Saeed, M. Search for Related Content PubMed PubMed Citation Articles by Jacquier, A. Articles by Saeed, M. Related Collections Related Article

Injection of Adeno-associated Viral Vector–Encoding Vascular Endothelial Growth Factor Gene in Infarcted Swine Myocardium: MR Measurements of Left Ventricular Function and Strain¹

¹ From the Department of Radiology, University of California San Francisco, 513 Parnassus Ave, HSW 207 B, San Francisco, CA 94134-0628. From the 2006 RSNA Annual Meeting. Received June 20, 2006; revision requested August 23; revision received October 25; accepted November 22; final version accepted February 12, 2007. Supported by grant RO1HL07295 from National Institutes of Health. A.J. is a research fellow supported by a postdoctoral research grant from the Société Française de Radiologie, Paris, France. Address correspondence to M.S. (e-mail: Maythem.Saeed{at}radiology.UCSF.edu).

Purpose: To prospectively investigate the long-term effect of adeno-associated viral (AAV) vector–encoding vascular endothelial growth factor gene (VEGF) (AAV-VEGF) on left ventricular (LV) mass and volumes, as well as on regional contractility and circumferential strain, in a swine model of reperfused myocardial infarction.

Materials and Methods: All experimental procedures received approval from the institutional committee on animal research. Of 16 pigs subjected to reperfused myocardial infarction, six were treated, six were controls, and four died during the ischemic intervention. In six animals, cardiac-specific AAV-VEGF was injected into the periinfarcted and infarcted myocardium 1 hour after reperfusion. Magnetic resonance (MR) imaging was performed at 3 days and 8 weeks after infarction by using cine, tagged, and delayed enhancement (with gadoterate meglumine) sequences to measure global and regional LV function and infarct size. At postmortem examination, tissue samples stained with isolectin B4, Masson trichrome, and hematoxylin-eosin were used to characterize injured myocardium. Two-tailed Student t test was used for statistical analysis.

Results: Six treated animals showed no change in mean LV ejection fraction after 8 weeks (40.3% ± 0.9 [standard error of the mean] vs 41.0% ± 0.7) in contrast to a decrease measured in six control animals (41.4% ± 0.7 vs 36.1% ± 0.6, P < .001). AAV-VEGF improved wall thickening and circumferential strain in periinfarcted and remote myocardium. A greater reduction in gadoterate meglumine–enhanced infarct area was measured in treated animals (18.6% ± 1.5 of the LV mass at 3 days vs 9.8% ± 1.0 of the LV mass at 8 weeks, P < .001) compared with control animals (17.7% ± 2.0 vs 14.8% ± 1.0, P = .008). Findings at histopathologic evaluation indicated an increase in vascular density and a decrease in myocyte diameter in the periinfarcted myocardium of treated, compared with control, animals.

Conclusion: Angiogenesis and arteriogenesis induced by VEGF genes improved regional myocardial strain and wall thickening and preserved ejection fraction after infarction.

© RSNA, 2007

Related Article

How Can Cardiac MR Imaging Help Guide Development of Gene Therapy for Treatment of Coronary Heart Disease?

Evan C. Unger
Radiology 2007 245: 1-2. [Full Text] [PDF]

This article has been cited by other articles:

				M. Saeed, A. Martin, A. Jacquier, M. Bucknor, D. Saloner, L. Do, P. Ursell, H. Su, Y. W. Kan, and C. B. Higgins Permanent Coronary Artery Occlusion: Cardiovascular MR Imaging Is Platform for Percutaneous Transendocardial Delivery and Assessment of Gene Therapy in Canine Model Radiology, September 9, 2008; (2008) 2491072068. [Abstract] [Full Text]

				M. Carlsson, N. F. Osman, P. C. Ursell, A. J. Martin, and M. Saeed Quantitative MR measurements of regional and global left ventricular function and strain after intramyocardial transfer of VM202 into infarcted swine myocardium Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H522 - H532. [Abstract] [Full Text] [PDF]

				A. J. Sinusas Targeted Imaging Offers Advantages Over Physiological Imaging for Evaluation of Angiogenic Therapy J. Am. Coll. Cardiol. Img., July 1, 2008; 1(4): 511 - 514. [Full Text] [PDF]

				E. C. Unger How Can Cardiac MR Imaging Help Guide Development of Gene Therapy for Treatment of Coronary Heart Disease? Radiology, October 1, 2007; 245(1): 1 - 2. [Full Text] [PDF]